Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001759425-25-000032
Filing Date
2025-05-07
Accepted
2025-05-07 16:08:12
Documents
84
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20250331.htm   iXBRL 10-Q 1433548
2 EX-31.1 mirm-10qq125xexx311.htm EX-31.1 10570
3 EX-31.2 mirm-10qq125xexx312.htm EX-31.2 11459
4 EX-32.1 mirm-10qq125xexx321.htm EX-32.1 5143
5 EX-32.2 mirm-10qq125xexx322.htm EX-32.2 5859
  Complete submission text file 0001759425-25-000032.txt   7353653

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20250331.xsd EX-101.SCH 55334
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20250331_cal.xml EX-101.CAL 79237
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20250331_def.xml EX-101.DEF 238599
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20250331_lab.xml EX-101.LAB 672295
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20250331_pre.xml EX-101.PRE 460285
87 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20250331_htm.xml XML 924136
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 25921374
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)